Suppr超能文献

社区居住老年人中抑郁症状与HMG-CoA还原酶抑制剂(他汀类药物)、皮质类固醇和组胺H2受体拮抗剂使用之间的关联:基于人群队列的横断面分析

Association between depressive symptoms and use of HMG-CoA reductase inhibitors (statins), corticosteroids and histamine H(2) receptor antagonists in community-dwelling older persons: cross-sectional analysis of a population-based cohort.

作者信息

Feng Liang, Tan Chay-Hoon, Merchant Reshma A, Ng Tze-Pin

机构信息

Gerontological Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

出版信息

Drugs Aging. 2008;25(9):795-805. doi: 10.2165/00002512-200825090-00005.

Abstract

BACKGROUND

Strong evidence supporting the existence of causal associations of drug use with depression is often lacking from empirical studies. Limited evidence suggests an inverse association of use of HMG-CoA reductase inhibitors (statins) with depressive symptoms. Sparse and sometimes conflicting data in this respect have also been reported for corticosteroids, histamine H(2) receptor antagonists and antihypertensive agents.

OBJECTIVE

To identify associations between use of different drug classes and depressive symptoms in community-dwelling older patients and to determine whether any such associations varied between young-old and old-old patients.

METHOD

We analysed cross-sectional data from a population-based cohort of 2804 older adults aged > or =55 years, in whom specific drug use was systematically identified from self-reports and physical inspection of medication labels. Depressive symptoms were determined using the 15-item Geriatric Depression Scale (GDS), with a GDS score > or =5 defining the presence of depressive symptoms.

RESULTS

Multivariate analysis controlling for the confounding effects of risk factors and correlates of depression revealed significant associations between depressive symptoms and use of statins (odds ratio [OR] 0.71; 95% CI 0.52, 0.97), histamine H(2) receptor antagonists for patients aged <65 years (OR 4.67; 95% CI 1.59, 13.74) and, in participants aged > or =65 years, systemic corticosteroids (OR 4.02; 95% CI 1.12, 14.42). No convincing associations between the presence of depressive symptoms and use of antihypertensives, antiparkinsonism drugs, NSAIDs and tranquilizers/hypnotic/sedatives were demonstrated.

CONCLUSION

The evidence in this study suggests a possible protective effect of statin use on depressive symptoms, and affirms a positive association between depressive symptoms and corticosteroid use, especially in the older elderly. Use of H(2) receptor antagonists was also associated with depressive symptoms, probably through their link with underlying dyspeptic syndromes.

摘要

背景

实证研究往往缺乏有力证据支持药物使用与抑郁症之间存在因果关联。有限的证据表明,使用HMG-CoA还原酶抑制剂(他汀类药物)与抑郁症状呈负相关。关于皮质类固醇、组胺H(2)受体拮抗剂和抗高血压药物,这方面的数据也很稀少,且有时相互矛盾。

目的

确定社区居住的老年患者中不同药物类别使用与抑郁症状之间的关联,并确定这些关联在年轻老年人和高龄老年人中是否存在差异。

方法

我们分析了来自一个基于人群的队列研究的横断面数据,该队列包括2804名年龄≥55岁的老年人,通过自我报告和药物标签的体格检查系统地确定了特定药物的使用情况。使用15项老年抑郁量表(GDS)确定抑郁症状,GDS评分≥5定义为存在抑郁症状。

结果

在控制了危险因素和抑郁症相关因素的混杂效应的多变量分析中,发现抑郁症状与他汀类药物的使用之间存在显著关联(优势比[OR]0.71;95%可信区间0.52,0.97),65岁以下患者使用组胺H(2)受体拮抗剂(OR 4.67;95%可信区间1.59,13.74),以及65岁及以上参与者使用全身性皮质类固醇(OR 4.02;95%可信区间1.12,14.42)。未发现抑郁症状的存在与抗高血压药物、抗帕金森病药物、非甾体抗炎药和镇静剂/催眠药/镇静剂的使用之间存在令人信服的关联。

结论

本研究中的证据表明他汀类药物使用可能对抑郁症状有保护作用,并证实了抑郁症状与皮质类固醇使用之间存在正相关,尤其是在高龄老年人中。组胺H(2)受体拮抗剂的使用也与抑郁症状有关,可能是通过它们与潜在消化不良综合征的联系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验